Pinnacle Associates’s Veracyte VCYT Stock Holding History

Pinnacle Associates’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.75M	Sell	103,258 -2,872	-3%	-$138K	0.05%	274
2026 Q2	$6.23M	Sell	106,130 -1,639	-2%	-$68.7K	0.07%	245
2026 Q1	$3.47M	Buy	107,769 +55,159	+105%	+$2.04M	0.04%	315
2025 Q4	$2.21M	Sell	52,610 -542	-1%	-$21.8K	0.03%	384
2025 Q3	$1.82M	Sell	53,152 -1,184	-2%	-$34K	0.02%	401
2025 Q2	$1.47M	Buy	54,336 +230	+0.4%	+$6.66K	0.02%	435
2025 Q1	$1.6M	Buy	+54,106	New	+$2.06M	0.02%	407

Other funds holding VCYT

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Vaughan Nelson Investment Management Houston, Texas $9.7B AUM 39.07% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Pinnacle Associates's VCYT Position: Q3 2026 in Review

Pinnacle Associates reduced its Veracyte (VCYT) stake by 2.7% in Q3 2026, selling an estimated $138K and leaving 103,258 shares worth $4.75M. The position accounts for 0.05% of the portfolio, ranked #274.

Pinnacle Associates first reported a position in VCYT in Q1 2025 and has held it in 7 quarters since. The position peaked at $6.23M in Q2 2026. 245 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

Pinnacle Associates held 103,258 shares of Veracyte worth $4.75M as of Q3 2026.
Pinnacle Associates sold 2,872 Veracyte shares in Q3 2026, an estimated $138K.
Veracyte made up 0.05% of Pinnacle Associates's portfolio in Q3 2026, its #274 holding.
Pinnacle Associates first reported a position in Veracyte in Q1 2025 and has held it in 7 quarters since.
Pinnacle Associates's Veracyte position peaked at $6.23M in Q2 2026.
245 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.